Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04128709 · ClinicalTrials.gov registry record · NA
Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use
A NA study of Urinary Bladder, Neurogenic, sponsored by Christopher Cooper.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04128709: Recruiting NA study of Urinary Bladder, Neurogenic, sponsored by Christopher Cooper.
NCT04128709 is a NA study of Urinary Bladder, Neurogenic that is actively recruiting participants, run by Christopher Cooper. The registered enrollment target is 50 participants, below the 64-participant average among 7 other Urinary Bladder, Neurogenic trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04128709, a NA study of Urinary Bladder, Neurogenic, is actively recruiting participants, sponsored by Christopher Cooper.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators have developed a novel pressure monitoring device that hooks to standard urinary catheters that are used by patients with a neurogenic bladder on daily clean intermittent catheterization. The device has already been demonstrated to be accurate compared to the gold standard in clinic urodynamics. This study will assess the patients and care givers ability and experience using the device in a home setting.
Primary Outcome
Utilization study of novel external device
Conditions Studied
Interventions
- DEVICE Urodynamics Testing
Study Locations (1)
Iowa
- University of Iowa Hospital and Clinics - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-11-19 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT04128709 shows while recruiting
NCT04128709 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 64-participant average among 7 other Urinary Bladder, Neurogenic trials with a reported enrollment target (22% lower).
The record links to 1 condition, with Urinary Bladder, Neurogenic appearing as the primary indexed condition, and to 1 intervention - of which Urodynamics Testing is the first listed.
NCT04128709 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT04128709 about?
NCT04128709 is a clinical study titled "Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use". The investigators have developed a novel pressure monitoring device that hooks to standard urinary catheters that are used by patients with a neurogenic bladder on daily clean intermittent catheterization. The device has already been demonstrated to be accurate compared to the gold standard in clini...
What is the current status of trial NCT04128709?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2019-11-19. Estimated completion is 2026-12.
What conditions does trial NCT04128709 study?
This clinical trial studies the following conditions: Urinary Bladder, Neurogenic.
What interventions are being tested in trial NCT04128709?
The interventions under investigation include: Urodynamics Testing (DEVICE).
Who is sponsoring clinical trial NCT04128709?
This trial is sponsored by Christopher Cooper, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04128709 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Bladder, Neurogenic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Recovery of Bladder and Sexual Function After Human Spinal Cord Injury
RECRUITING · NA
-
Cystoealstometer (Bladder Monitor Device)-Home Use
ACTIVE NOT RECRUITING · NA
-
Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI)
COMPLETED · NA
-
Connected Catheter Clinical Feasibility Study( CFS)
COMPLETED · NA
-
NXT Post-Market Clinical Follow-up
RECRUITING
-
Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI